This session will provide an overview of the current federal income tax treatment of research and experimental (R&E) expenditures paid or incurred in connection with a trade or business under section 174, as well as the TCJA’s modifications thereto for amounts paid or incurred in taxable years beginning after December 31, 2021. The panel will discuss the latest legislative proposal(s) to repeal or delay those modifications and consider the range of potential implications for in-house tax professionals, including accounting method and other planning opportunities, practical data management tips, additional tax compliance and reporting burdens, financial statement and tax provision impacts, among others.
After this session, participants will be able to:
Under the potential change from the current and proposed changes to the treatment of R&E expenditures
Understand the potential impact on their financial statements
Apply potential planning opportunities
Understand the additional tax compliance and reporting burden
Director, Taxes, Head of Tax| Member, TEI's Executive Committee,
Infinite Electronics, Inc.
Managing Director – Research Credit and Incentive Services,
Alvarez & Marsal Taxand, LLC